Form 4: Verizon Executive Kyle Malady Sells Shares

Verizon's EVP and Group CEO, Kyle Malady, sold 11,085 shares of common stock on January 29, 2025.

Summary

• Kyle Malady, an Executive Vice President and Group CEO at Verizon, sold 11,085 shares of Verizon common stock on January 29, 2025.
• The sale was executed at a price of $40.88 per share.
• Following the transaction, Malady directly owns 14,590 shares of Verizon common stock.
• He also indirectly owns 18,107 shares through a 401(k) plan.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by an executive, with no inherent positive or negative sentiment.

Industry Context

This is a routine SEC Form 4 filing, which is common for corporate executives who trade their company's stock. It provides transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical executive stock sales.
• Similar filings are made by executives at companies like AT&T (T) and T-Mobile (TMUS) when they trade their company's stock.

Stakeholder Impact

• This transaction is unlikely to have a significant impact on stakeholders, as it is a routine sale by an executive.

Key Dates

Keywords

Verizon, Kyle Malady, stock sale, insider trading, executive, common stock, VZ